BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paston SJ, Brentville VA, Symonds P, Durrant LG. Cancer Vaccines, Adjuvants, and Delivery Systems. Front Immunol 2021;12:627932. [PMID: 33859638 DOI: 10.3389/fimmu.2021.627932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Parums DV. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine. Med Sci Monit 2021;27:e933088. [PMID: 33994538 DOI: 10.12659/MSM.933088] [Reference Citation Analysis]
2 Fuentes R, Aguinagalde L, Pifferi C, Plata A, Sacristán N, Castellana D, Anguita J, Fernández-tejada A. Novel Oxime-Derivatized Synthetic Triterpene Glycosides as Potent Saponin Vaccine Adjuvants. Front Immunol 2022;13:865507. [DOI: 10.3389/fimmu.2022.865507] [Reference Citation Analysis]
3 Vlachonikola E, Stamatopoulos K, Chatzidimitriou A. T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:3255. [PMID: 34209724 DOI: 10.3390/cancers13133255] [Reference Citation Analysis]
4 Hoteit M, Oneissi Z, Reda R, Wakim F, Zaidan A, Farran M, Abi-Khalil E, El-Sibai M. Cancer immunotherapy: A comprehensive appraisal of its modes of application. Oncol Lett 2021;22:655. [PMID: 34386077 DOI: 10.3892/ol.2021.12916] [Reference Citation Analysis]
5 Yang L, Ning Q, Tang S, Cui D. Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/8052212] [Reference Citation Analysis]
6 Zheng Y, Zhong Z. Roadmap to next-generation cancer vaccines. J Control Release 2022:S0168-3659(22)00260-7. [PMID: 35561869 DOI: 10.1016/j.jconrel.2022.05.005] [Reference Citation Analysis]
7 Trofimova O, Korotkaja K, Skrastina D, Jansons J, Spunde K, Isaguliants M, Zajakina A. Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model. Vaccines (Basel) 2021;9:1247. [PMID: 34835178 DOI: 10.3390/vaccines9111247] [Reference Citation Analysis]
8 Zhang J, Fan J, Skwarczynski M, Stephenson RJ, Toth I, Hussein WM. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. IJN 2022;Volume 17:869-900. [DOI: 10.2147/ijn.s269986] [Reference Citation Analysis]